Blog / 11 Stocks: 9 Dividend Payers 2 For Growth

11 Stocks: 9 Dividend Payers 2 For Growth

Introduction Stocks

Not all stocks are the same, and not all stocks serves the investor’s needs.  Even though investors tend to think stocks come into primary categories – growth and dividend income – there are many nuances. Therefore, investors are given the options and abilities to blend stocks with different characteristics into portfolios that meet their specific goals, objectives ,risk tolerances, and needs.


Subscribers to this channel often ask to have specific companies covered.  Unfortunately, these requests are too numerous to be able to provide comprehensive research on.  However, we found that one of the big advantages of the FAST Graph research tool is its ability to instantly show investors whether a stock is worthy of spending the time and effort to research deeper or not.  Therefore, we are experimenting with what we are calling two-minute drill analysis.  With this category we will provide a short review of as many companies as we can that have been requested by subscribers.  From there we leave it up to the subscriber to decide whether they want to go further or not.  This video is installment number 1.

FAST Graphs Analyze Out Video on Cigna Group (CI), Elevance Health (ELV), Johnson & Johnson (JNJ), Main Street Capital (MAIN), Medifast (MED), Magna International (MGA), Merck & Co (MRK), Moderna (MRNA), Ulta Beauty (ULTA), Union Pacific (UNP), Walgreens Boot Alliance (WBA)

FAST Graphs Analyze Out Loud Video

Try FAST Graphs for FREE Today!

SUBSCRIBE to our YouTube Channel

Click here for our Research Articles

Disclosure: Long CI, ELV, JNJ, MGA, MRK, WBA

Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.